Cargando…

Enhanced Efficacy of Radiopharmaceuticals When Using Technetium-99m-Labeled Liposomal Agents: Synthesis and Pharmacokinetic Properties

Challenges posed by the retention of radiopharmaceuticals in unintended organs affect the quality of patient procedures when undergoing diagnostics and therapeutics. The aim of this study was to formulate a suitable tracer encapsulated in liposomes using different techniques and compounds to enhance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkandari, Anfal M., Alsayed, Yasser M., El-Hanbaly, Atallah M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687670/ https://www.ncbi.nlm.nih.gov/pubmed/36428563 http://dx.doi.org/10.3390/biomedicines10112994

Ejemplares similares

Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures
por: Maioli, Claudio, et al.
Publicado: (2017)

Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients.
por: Richardson, V. J., et al.
Publicado: (1979)

Click-to-Chelate: Development of Technetium and Rhenium-Tricarbonyl Labeled Radiopharmaceuticals
por: Kluba, Christiane A., et al.
Publicado: (2013)

Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities
por: Boschi, Alessandra, et al.
Publicado: (2022)

Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands
por: Martini, Petra, et al.
Publicado: (2018)

Alternative chromatographic system for the quality control of lipophilic technetium-99m radiopharmaceuticals such as [(99m)Tc(MIBI)(6)](+)
por: Faria, D.P., et al.
Publicado: (2015)

New leads for fragment-based design of rhenium/technetium radiopharmaceutical agents
por: Brink, Alice, et al.
Publicado: (2017)

Technetium-99m-labeled genistein as a potential radical scavenging agent
por: Ramdhani, Danni, et al.
Publicado: (2019)

Synthesis of multidentate ligands with amido or amino donor groups for the preparation of rhenium and technetium radiopharmaceuticals
por: Al-Nuzal, S. M. D., et al.
Publicado: (2012)

Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate
por: Gundogdu, Evren, et al.
Publicado: (2020)

Labeling of Tannic Acid with Technetium-99m for Diagnosis of Stomach Ulcer
por: Ibrahim, I. T., et al.
Publicado: (2011)

Evaluation of Deoxyribonucleic Acid Toxicity Induced by the Radiopharmaceutical (99m)Technetium-Methylenediphosphonic Acid and by Stannous Chloride in Wistar Rats
por: De Mattos, José Carlos Pelielo, et al.
Publicado: (2012)

Effect of Ursodeoxycholic Acid on the Biodistribution and Excretion of Technetium-99m Radiopharmaceuticals in Rat: A Potential Image Quality Enhancer
por: Han, Yeon-Hee, et al.
Publicado: (2021)

Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes
por: De Silva, Leanne, et al.
Publicado: (2019)

Direct Technetium radiopharmaceuticals production using a 30MeV Cyclotron
por: Jalilian, AR., et al.
Publicado: (2011)

Technetium-99m Labeled Tropane Derivative: Uptake in a Pituitary Macroadenoma
por: Angamuthu, Meivel, et al.
Publicado: (2019)

Alendronate-coated long-circulating liposomes containing (99m)technetium-ceftizoxime used to identify osteomyelitis
por: Ferreira, Diego dos Santos, et al.
Publicado: (2015)

Technetium-99m Tricarbonyl Labeled a Broad-spectrum Quinolone as a Specific Imaging Agent in Infection Diseases
por: Khoramrouz, Seyed Javad, et al.
Publicado: (2017)

Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes
por: Shimizu, Yoichi, et al.
Publicado: (2021)

Effect of Thuya occidentalis on the labeling of red blood cells and plasma proteins with technetium-99m.
por: Oliveira, J. F., et al.
Publicado: (1996)

Diagnosis of bone infection by complementary role of technetium-99m MDP and technetium-99m hexamethylpropylene-amineoxime-leukocytes
por: Al-Zahrani, Abdullah, et al.
Publicado: (2012)

Recent Progress in Technetium-99m-Labeled Nanoparticles for Molecular Imaging and Cancer Therapy
por: Mushtaq, Sajid, et al.
Publicado: (2021)

[(99m)Tc]Technetium-Labeled Niosomes: Radiolabeling, Quality Control, and In Vitro Evaluation
por: Ekinci, Meliha, et al.
Publicado: (2023)

Evaluation of technetium-99m decay on Escherichia coli inactivation: effects of physical or chemical agents.
por: Silva, C. R., et al.
Publicado: (1998)

Use of autologous (99m)Technetium-labelled neutrophils to quantify lung neutrophil clearance in COPD
por: Tregay, Nicola, et al.
Publicado: (2019)

Evaluation of technetium-99m metastable nanocolloid as an imaging agent for performing milk scans
por: Evbuomwan, Osayande, et al.
Publicado: (2019)

Clinical application of autologous technetium-99m-labelled eosinophils to detect focal eosinophilic inflammation in the lung
por: Loutsios, Chrystalla, et al.
Publicado: (2015)

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015)

Brain targeting efficiency of intranasal clozapine-loaded mixed micelles following radio labeling with Technetium-99m
por: Sayed, Sinar, et al.
Publicado: (2021)

Technetium-99m production issues in the United Kingdom
por: Green, Christopher H.
Publicado: (2012)

Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
por: Kim, S. E., et al.
Publicado: (1994)

Evaluation of Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivatives as Potential EGFR Agents
por: Makrypidi, Konstantina, et al.
Publicado: (2023)

Transportal Technetium-99m Labeled Macroaggregated Albumin Scintigraphy to Quantify Occult Intrahepatic Microvascular Portosystemic Shunting
por: De la Garza-Ramos, Cynthia, et al.
Publicado: (2021)

Technetium-99m-Labeled Autologous Serum Albumin: A Personal-Exclusive Source of Serum Component
por: Wang, Yuh-Feng, et al.
Publicado: (2011)

Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.
por: Moore, R. B., et al.
Publicado: (1992)

Hybridised production of technetium-99m and technetium-101 with fluorine-18 on a low-energy biomedical cyclotron
por: Johnstone, Erik V., et al.
Publicado: (2023)

Options for UK Technetium-99m Production using Accelerators
por: H.L. Owen, et al.
Publicado: (2014)

Recent Levels of Technetium-99 in Seawater at the West Coast of Svalbard
por: Gerland, Sebastian, et al.
Publicado: (2002)

99m-Technetium Sestamibi Uptake in a Gastric Schwannoma
por: Shawgi, Mohamed, et al.
Publicado: (2018)

Innovative Target for Production of Technetium-99m by Biomedical Cyclotron
por: Skliarova, Hanna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k3o6h06nai4g44jc8b39s7smpd